Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients - Bajaj, M; Suraamornkul, S; Hardies, L J (Int J Obes Relat Metab Disord, 2004)
et al.